FTC Asks For ‘Pharma Bro’ Martin Shkreli to Be Held in Contempt
Published
The Federal Trade Commission has a bone to pick with 'Pharma Bro' Martin Shkreli – again. Despite being banned from the pharmaceutical industry after he notoriously hiked the price of a lifesaving drug from $13.50 to $750 in 2015, in addition to serving five years in prison for securities fraud,…
#pharmabro #martinshkreli #ftc #shkreli #druglikeinc #sambankmanfriedahead